Impact of abdominal obesity on the frequency of hypertension and cardiovascular disease in Poland – Results from the IDEA study (International Day for the Evaluation of Abdominal Obesity)

References

• World Health Statistics 2009, World Health Organization, 2009, Mortality and burden of disease, WHO website: http://www.who.int/whosis/; accessed 1 January 2010.
   Google Scholar
• Virgin SE, Schmitke JA. Metabolic syndrome. AAOHN Journal. 2003;51:28–37.
   PubMedGoogle Scholar
• Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome – A new worldwide definition. Lancet. 2005;366:1059–1062.
   PubMed Web of Science ®Google Scholar
• Wyrzykowski B, Zdrojewski T, Bandosz P. Metabolic syndrome in Poland. Kardiol Pol. 2005;62 Suppl 2:30–35.
   Google Scholar
• Chrostowska M., Szczech R., Narkiewicz K. Antihypertensive therapy in the obese hypertensive patient. Curr Opin Nephrol Hypertens. 2006;15:487–492.
   PubMed Web of Science ®Google Scholar
• Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, . Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008;87: 1212–1218.
   PubMed Web of Science ®Google Scholar
• Freemantle N, Holmes J, Hockey A, Kumar S. How strong is the association between abdominal obesity and the incidence of type 2 diabetes? Int J Clin Pract. 2008;62:1391–1396.
   PubMed Web of Science ®Google Scholar
• Francesco Branca HNTL. The challenge of obesity in the WHO European Region and the strategies for response. www.euro.int./document/E90711.pdf; 2007.
   Google Scholar
• Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, . on behalf of the INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: A case-control study. Lancet. 2005;366:1640–1649.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S. Effects of potentially modifiable risk factors associated with myocardial infarction in 52 countries, the INTERHEART study: Case control study. Lancet. 2004;364:937–952.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity: Preventing and managing the global epidemic – Report of a WHO consultation on obesity. Geneva: WHO; 1998.
   Google Scholar
• Okosun IS, Chandra KM, Boev A, Boltri JM, Choi ST, Parish DC, . Abdominal adiposity in U.S. adults: Prevalence and trends, 1960–2000. Prev Med. 2004;39: 197–206.
   PubMed Web of Science ®Google Scholar
• Seidell JC, Kahn HS, Williamson DF, Lissner L, Valdez R. Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr. 2001;73:123–126.
   PubMedGoogle Scholar
• National Heart, Lung, and Blood Institute's Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. Am J Clin Nutr. 1998;68:899–917.
   Google Scholar
• Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith SC Jr, . International Day for the Evaluation of Abdominal Obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients in 63 countries. Circulation. 2007;116: 1942–1951.
   PubMed Web of Science ®Google Scholar
• Wittchen H-U, Balkau B, Massien C, Richard A, Haffner S, Després J-P, on behalf of the IDEA Steering Committee. International Day for the Evaluation of Abdominal obesity: Rationale and design of a primary study on the prevalence of abdominal obesity and associated factors in 63 countries. Eur Heart J. 2006;8 Suppl B:B26–B33.
   Google Scholar
• Pouliot M, Després J, Lemieux S. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–468.
   PubMed Web of Science ®Google Scholar
• Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555–563.
   PubMed Web of Science ®Google Scholar
• Fox KAA, Després J-P, Richard A-J, Brette S, Deanfield JE. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91 246 ambulant patients in 27 European countries. Eur Heart J. 2009;30:3055–3063, published ahead of print September 23, 2009. doi:10.1093/eurheartj/ehp371
   PubMed Web of Science ®Google Scholar
• Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring). 2006;14 Suppl 5:242S–249S.
   PubMedGoogle Scholar
• Gimeno RE, Klaman LD. Adipose tissue as an active endocrine organ: Recent advances. Curr Opin Pharmacol. 2005;5: 122–128.
   PubMed Web of Science ®Google Scholar
• Calabro P, Yeh ET. Obesity, inflammation, and vascular disease: The role of the adipose tissue as an endocrine organ. Subcell Biochem. 2007;42:63–91.
   PubMedGoogle Scholar
• Kobayashi K. Adipokines: Therapeutic targets for metabolic syndrome. Curr Drug Targets. 2005;6:525–529.
   PubMed Web of Science ®Google Scholar
• Zdrojewski T, Szpakowski P, Bandosz P, Pajak A, Wiecek A, Krupa-Wojciechowska B, . Arterial hypertension in Poland in 2002. J Human Hypertens. 2004;18:557–562.
   PubMed Web of Science ®Google Scholar
• Zdrojewski T., Bandosz P., Szpakowski P. , Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce, wyniki badania Natpol Plus. Kardiologia Polska. 2004;61 Supp IV.
   Google Scholar
• The World Health Report. Reducing risks, promoting healthy life. WHO: Geneva; 2002.
   Google Scholar